21st century healthcare: Medical McCarthyism, when errors become crimes

Until COVID-19 became a issue, historically… medical errors was the third largest cause of death. After Cancer and cardiovascular. Has the DOJ and our judicial system got a “taste of blood” as more and more prescribers are being taken to court over mostly fabricated violations of the Controlled Substance Act.  As more and more District Attorneys are refusing to charge many criminals, is those in our judicial system just looking for any case that they can justify their paycheck ?

Selective Outrage in Healthcare, RaDonda Vaught vs. William Husel

https://www.daily-remedy.com/selective-outrage-in-healthcare-radonda-vaught-rn-vs-william-husel-do/

We lie all the time.

We pretend to care about things we really do not and we pretend not to care about things that we really do. We have no consistent parameters guiding our behavior.

We watch identical acts of injustice or see similar tragedies unfolding and have vastly different perceptions. Behavioral economists call this the empathy gap.

We underestimate the influence of subjective beliefs on our own behavior and make decisions that only satisfy our current perceptions. It explains why the loss of European lives in Ukraine attracts greater media attention than the loss of lives of Central Asians in Afghanistan. This is not a new phenomenon.

But it appears in healthcare in uniquely unprecedented ways. The increasing government encroachment into healthcare has led to a slew of highly publicized criminal cases that were previously addressed more privately as regulatory concerns. Now medical errors are criminal acts.

This may be tragic enough, but our wavering response to these tragedies adds a veneer of shame to a dark time in healthcare, and will prove to be an indelible stain on our medical history.

Recently, a nurse in Tennessee named RaDonda Vaught was convicted for murder for what otherwise would be deemed a medical error. While a fatal error, it was an error nonetheless, that took place over the course of patient care. It should have been handled by the state’s medical licensing board and nurse oversight committees.

Instead, local prosecutors took it upon themselves to indict and inflict a vicious display of retaliatory justice in which Vaught found herself convicted by a jury for a medical error. The ramifications were quick and powerful.

Nurses all over the country shouted in protest. Nurses quit. The American Nurses Association issued a statement of concern:

“The nursing profession is already extremely short-staffed, strained and facing immense pressure – an unfortunate multi-year trend that was further exacerbated by the effects of the pandemic. This ruling will have a long-lasting negative impact on the profession.”

The outrage in support for Vaught was commendable. It shows a strong sense of solidarity in support of one healthcare worker. Such displays of support are sorely needed. And have strong reason to believe the government encroachment that led to Vaught’s conviction will be challenged. We likely have not heard the last of this case.

What we have not heard of is another ruling, that of an acquittal, for a physician who was indicted for prescribing fentanyl as a form of palliative care for hospice patients under his care. Dr. William Husel was indicted on fourteen counts of murder for treating patients with fentanyl to relieve their pain in the last days of their lives.

He violated no protocol. He adhered to clinical standards of care. He simply prescribed fentanyl at a dose that a non-medically trained prosecutor somehow believed to be excessive and therefore criminal. There was no clinical or legal basis for the charges. Yet he was made to endure a two month trial for what amounts to practicing clinical medicine.

Yet there is no outrage against the prosecutors in this case. No congratulatory support for the physician who risked life imprisonment to challenge bogus claims of criminality.

Why the glaring difference in response from the public?

At least in the cause of Vaught, an error took place. But Dr. Husel committed no error and ensured a pain-free quality of life for patients at the end of their lives. We clamor for justice in one case, and remain silent for the other.

This is what the empathy gap looks like in healthcare. And it is why little has been done to reign in government encroachment in healthcare. We have no consistent response to individual acts of injustice and therefore no consistent means of challenging government misconduct. Shakespeare recognized as much centuries ago when he wrote the following lines in The Merchant of Venice:

If you prick us, do we not bleed?

If you tickle us, do we not laugh?

If you poison us, do we not die?

The lines allude to the lack of compassion we hold for some but carry in abundance for others. It shows how empathy waxes and wanes and leads to different reactions to similar events. It is why Vaught’s conviction led to national outrage and why Husel’s acquittal hardly registered a blip on the national radar.

Healthcare is facing unprecedented pressure from a government encroaching more and more into healthcare. It has induced a state of fear and artificial conformity – a veritable state of Medical McCarthyism.

It manifests when we see errors become crimes. Yet, our inconsistent responses have allowed this to go on. We feign selective outrage when we see someone we can relate to being attacked. We ignore or show disdain when we see someone we cannot relate to being attacked.

Accordingly, our perceptions flutter. Of course, the physician deserved to be indicted. Of course, the physician got away with it. But the poor nurse, she must be a victim. Even if she made an error, she should not be criminalized for an error that could have happened to anyone.

We attribute systemic errors to the individual when convenient. And we remember the nuance in systemic problems when we can identify with the individual. There are no consistent parameters in our response.

It all depends on the perceptions we hold, fluttering amidst the winds of outrage, emerging out of the void of the unknown, where we find the empathy gap.

East Brady woman sues CVS over face mask dispute


East Brady woman sues CVS over face mask dispute

https://www.butlereagle.com/20220425/east-brady-woman-sues-cvs-over-face-mask-dispute/

An East Brady woman has filed a lawsuit against CVS alleging she had no alternative but to resign because the company would not allow her to wear a face shield instead of a face mask that caused her to faint.

Through her attorney, Brittany Beham filed the suit in Butler County Common Pleas Court against Pennsylvania CVS Pharmacy, LLC, which operates the CVS inside the Target in Butler Commons in Butler Township where she worked as a pharmacy intern from March 2016 to September 2020, according to the suit.

Beham suffers from panic disorder with syncopal, or fainting episodes, and experienced several episodes from March through June of 2020 as a result of wearing a face mask, according to the suit.

During that time, she claims that she told her supervisor on several occasions that wearing a mask was causing the episodes. While on short-term disability leave from June 18 to July 21, 2020, she was treated by a therapist, but could not take anti-anxiety medicine because she was pregnant, according to the suit.

She completed and submitted a reasonable accommodation questionnaire, asking for permission to wear a face shield instead of a mask to prevent further episodes, and submitted a note from a nurse at Butler Health System Women’s Care Associates, saying she cannot wear a mask due to the episodes, but she can wear a shield.

Pfizer recalls some batches of blood pressure drug over carcinogen presence

Pfizer recalls some batches of blood pressure drug over carcinogen presence

Pfizer has yet to receive any reports of adverse effects related to the recalled batches

https://www.foxbusiness.com/healthcare/pfizer-recalls-batches-blood-pressure-drug-carcinogen

Pfizer said Friday it was voluntarily recalling five batches of its Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine.

The drugmaker said it was not aware of any reports of adverse events related to the recalled batches, which were distributed in the United States and Puerto Rico from December 2019 to April 2022.

Pfizer Canada also recalled all lots of three doses of Accupril Thursday after finding the same impurity to be above acceptable levels.

Pfizer said there was no immediate risk to patients taking this medication, in which the agent, a nitrosamine, was found.

 Exterior view of a Pfizer building in Berlin.  (Ulrich Baumgarten via Getty Images / Getty Images)

Nitrosamines are common in water and foods, but exposure above acceptable levels over long periods of time could increase the risk of cancer.

Pfizer last month also recalled some batches of another blood pressure drug, Accuretic, and two authorized cheaper versions due to the presence of the possible carcinogen.

Japan’s Shionogi says COVID-19 pill shows rapid clearance of virus

Japan’s Shionogi says COVID-19 pill shows rapid clearance of virus

The company has global aspirations for the antiviral pill

https://www.foxbusiness.com/healthcare/japans-shionogi-says-covid-19-pill-shows-rapid-clearance-virus

An experimental treatment from Shionogi & Co. Ltd. has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drugmaker said Sunday.

The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus,” Shionogi said in a statement, citing results from a clinical trial of the drug.

The company has global aspirations for the antiviral pill, which is now being evaluated by Japanese regulators.

The findings released Sunday also showed “there was no significant difference in total score of 12 COVID-19 symptoms between treatment arms,” although the drug showed improvement in a composite score of five “respiratory and feverish” symptoms, Shionogi said.

 A ground crew member moves pallets of a shipment of Pfizer’s antiviral COVID-19 pills, Paxlovid, as they arrive at an Incheon International Airport cargo terminal Jan. 13, 2022, in Incheon, South Korea. ( Jung Yeon-Je, Pool/Getty Images / Getty Images)

The drugmaker said in March it would launch a global trial for the drug with U.S. government support, and Chief Executive Isao Teshirogi has said production could reach 10 million doses a year.

Shionogi’s shares have been on a roller coaster on speculation about success of the treatment. The stock climbed Friday after a report the U.S. government is in talks to acquire supplies of the drug.

Biologics for JIA? Not So Fast, Say Insurers

Biologics for JIA? Not So Fast, Say Insurers

— Nearly all required prior authorization in a small study, and requests often rejected at first

https://www.medpagetoday.com/rheumatology/arthritis/98368

A photo of a young girl holding her painful hand.

It’s not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found.

Among 54 patients seen at Boston Children’s Hospital for newly diagnosed JIA in 2018-2019, their insurers required prior authorization for all but one, according to researchers there led by Jordan E. Roberts, MD.

And for 14 of those, the initial requests were denied, the group reported in JAMA Network Open. Four of the patients ended up taking another type of medication because of the denials, although TNF inhibitors were eventually approved for all 54.

That latter finding indicates that insurers’ policies “present barriers to care despite appropriate specialty medication requests,” Roberts and colleagues argued — a situation also faced by adults with rheumatoid arthritis and similar conditions for which TNF inhibitors are a standard of care.

In many cases, insurers insisted on particular forms of “step therapy” with either (or both) nonsteroidal anti-inflammatory drugs (NSAIDs) or nonbiologic disease-modifying anti-rheumatic drugs (DMARDs) before they would authorize TNF inhibitors.

For some patients, insurers demanded that patients receive a different TNF inhibitor from that prescribed by clinicians. Four such patients, for example, were required to take adalimumab (Humira) instead of etanercept (Enbrel) or infliximab (Remicade). “Infliximab’s intravenous formulation allows for more precise weight-based dosing than subcutaneously administered [TNF inhibitors],” Roberts and colleagues pointed out.

In other cases the insurer simply decreed that TNF inhibitors were not a “medical necessity,” even though clinicians judged that their patients were not responding adequately to nonbiologic therapy. TNF inhibitors are “strongly recommended” in the most recently published guidelines, and were already central to treatment as far back as 2011.

In fact, 91% of the patients in the Boston Children’s study had previously received conventional DMARDs and 61% had taken NSAIDs. Mean patient age was 10 and just over half were girls; no particular JIA subtype was predominant.

Median active joint count was 2 (interquartile range 1-4) when TNF inhibitors were first recommended, and medians for patient/parent and clinician global assessments stood at 3 on a 10-point scale, with 10 representing the most burdensome disease.

Both figures suggest that most patients were experiencing some degree of difficulty that TNF inhibitor therapy could help relieve.

Public insurance (n=10) was no better than private in terms of the barriers erected, the admittedly limited data indicated. Denials of initial requests ensued in 30% of these cases, compared with 25% of patients covered by private insurance, and median times to approve prior authorization and to start TNF inhibitor treatment after the requests were made were similar (2.5 vs 3 days and 20 vs 24 days, respectively).

While a 3-week wait to begin recommended therapy may not seem long, Roberts and colleagues observed that early aggressive treatment has been tied to improved outcomes.

Limitations to the study were the small number of patients and its location in Massachusetts, where Medicaid is “relatively comprehensive”; formularies differ considerably among state Medicaid programs as well as among private insurers.

In this small study – mean aged of pt was 10 y/o – and bodily damage caused by juvenile idiopathic arthritis (JIA) is NON-REVERSIBLE so the denial by these insurance companies – per this survey … the time between first being prescribed and receiving the TNF inhibitor … Initially the joint damage on a 1-10 scale was a TWO and by the time that the insurance companies stopped playing around – THREE WEEKS – with prior authorizations… the joint damage had progress ONE WHOLE POINT.

ALL HAT AND NO CATTLE


Isn’t there someone in Rhode Island that professes to be a strong advocate for chronic pain pts ?  I know when people reach out to me, I try to get back with them the same day and no later than the next day. I have been watching the TV show YELLOWSTONE and they have a phrase they use that may be appropriate here ” “they” must be ALL HAT AND NO CATTLE”  To make sure that I was correct about the definition.  I found this on the web https://wordhistories.net/2020/12/07/all-hat-no-cattle/  to have or cultivate a particular image or reputation which has no basis in reality

Why employees of major pharmacy chains are quitting their jobs


It’s my last day at the WAG and this is my final (i think) draft of the email that I‘ll send to upper management as I end my shift. I held back many unprofessional words but also wanted them to hear my frustration for not just myself but all other pharmacists and techs.

This is a final “goodbye letter” to Walgreen after 7 yrs working up to being a pharmacy manager. All the things/tasks that this tech is referencing in this letter is in the industry as “metrics”.  Generally this is something that your local independent pharmacy doesn’t worry about. When I had my own independent pharmacy… the “metrics” that I looked at… was the number of prescriptions filled and $$ generated this month compared to the previous month or the same month one year ago..  Once a month that took – MAYBE – 10-15 minutes of my time.  If my pharmacy was filling more prescriptions and generated more revenue – it was easy to come to the conclusion that we were doing something right…  if those numbers did not increase, we were doing something wrong and we need to find out what it is and how we make adjustments.  These pharmacy chains seem to want to over analyzes even minute details. Often they waste all of these staff hours trying to figure out how they could cut staff hours and generate more profits for the corporation. When work feels more like a battlefield, it’s essential to take steps to cope and improve your experience.

If you patronize a chain pharmacy and you wonder why you have to wait too damn long to get your prescriptions filled… or the pharmacy doesn’t have your meds in stock or why the Rx dept staff looks like they are running on a tread mill all the time… or why you can’t get them to answer the phone when you call.

If you are tired of being treated just like another number when you are trying to get your necessary medication filled… here is a hyperlink to find a independent pharmacy by zip code https://ncpa.org/pharmacy-locator

APDF runs on donations – please use these apps to donate

I’m looking for someone from Michigan affected by the high costs of insulin for a reporter


I’m looking for someone from Michigan affected by the high costs of insulin for a reporter. Here’s the info. You can call. Today, I’m wrapping up a story on drug prices, and that includes the Afford Insulin Now Act that would cap insulin cost-sharing at $35 — at least for some people.
. Unfortunately, I’m on a tight deadline. Might you know anyone in Michigan who can help? The best way to reach me is 734-725-1155. Please feel free to share that number.
Many thanks for all the help. Unfortunately, I’m on a tight deadline. Might you know anyone in Michigan who can help? The best way to reach me is 734-725-1155. Please feel free to share that number.
Many thanks,
Robin Erb
Michigan Health Watch
Read my latest.
Bridge Michigan
(734) 725-1155

‘Euthanasia Pivots on Intent:’ Physician Witnesses in Husel Trial Speak Out

‘Euthanasia Pivots on Intent:’ Physician Witnesses in Husel Trial Speak Out

Physician expert witnesses on either side of the Husel trial dive into case’s gray areas

https://www.medpagetoday.com/special-reports/exclusives/98345

Joel Zivot, MD, of Emory University in Atlanta, was the only witness called by the defense. Wes Ely, MD, of Vanderbilt University and the Nashville VA, was one of 53 witnesses called by the prosecution.

In this exclusive MedPage Today video, Zivot and Ely discuss the finer points of the case, such as the lack of guidelines on end-of-life opioid dosing, plus the intent of relieving pain versus the intent of shortening the dying process.

A transcript of the conversation follows:

Zivot: I think that the issues around the Husel case — there was a lot of focus on dosage, and I understand where the concern around dosage would be relevant. In medicine, we spend a lot of time thinking about dosage. Many other kinds of medications that we administer, of course, have an associated dosage with them.

Now what’s tricky about opioids is that, with respect to specific dose, we understand that there’s a variety of responses that can occur as a consequence of things like prior exposure, or the intangible problem of how much pain a person is actually having. If I’m giving a medication, for example for high blood pressure, I’ve got a very nice sharp target and I know when I’ve achieved that dose. On the other hand, the intangible problem of pain, especially around the time of death, is very difficult to measure.

And so the only thing that we can know is by engaging our empathy. We have to look at a person and imagine, if we were them, what it might feel like as we dose them.

I think that the practice reflects this in that if one looks at the literature, people are very careful not to say that one must only give dose “X” in every case. The American Medical Association, for example, when it talks about this really just specifies a quantity necessary to achieve the desired goal

Ely: Standard doses of analgesics opiates — opioids for relieving pain — really center around, for fentanyl, in the 50 micrograms to 100/200 microgram ranges as starting doses. We have to talk explicit numbers, but those numbers are not hard and fast.

The key is that if our goal, if our intent is to relieve suffering, we have to balance the risk and the benefit of the drug. So that’s why with fentanyl, for example, we would start in the 50 microgram to 100 microgram range, and then we would go up if the patient, as Dr. Zivot said, still exhibited signs of pain.

What we don’t do with these drugs is immediately jump to doses 10 or 20 times higher — that 1,000 to 2,000 micrograms — without first going with the lower doses, because the lower doses could achieve pain relief without the main problem of completely suppressing the drive to breathe. Because these drugs will suppress the drive to breathe of the brain, and fentanyl will also create intense chest stiffness that prevents someone from breathing, too. We see that all the time in the operating room.

So, the standard doses aren’t hard and fast, but the general idea is if your intent is to relieve pain: start low, go high. Don’t start way high because of the potential downsides. And as you move to the way high doses, that’s where you shift from intent [to relieve] pain to something like — for example, in countries that have legalized euthanasia — an intentional shortening of the dying process.

Zivot: Well you know, Wes, you and I of course go back in our relationship. And what I think is interesting is that you and I share some important views. So, for example, we both have grave concerns about the practice of euthanasia. We both have said publicly that we are against euthanasia. And I would stand by that now.

When I think about the Husel case, I think that when I reviewed the records, I thought that Husel was not practicing euthanasia. When you reviewed the records, perhaps that’s what you thought — that he was practicing euthanasia. And it is further, perhaps, your position — and you can correct me if I’m wrong — that euthanasia here equates with murder. Maybe that’s the place where we found ourselves at odds.

You know, the court is very limited in terms of how it can manage these sorts of things. In the conversations between physicians and in the house of medicine, we’re capable of having a more nuanced conversation. But the court is very specific as to what it means to murder, and murder, I think, was what was at stake here and murder was the problem.

Ely: Yeah. I like your answer a lot, Joel. And I don’t know what Dr. Husel’s intent was, I never claimed to know Dr. Husel’s intent, and euthanasia does pivot on intent. So, if I intentionally am doing something to shorten your dying process, that is wrong and it’s against the law. If I am intending to relieve your suffering, that is not against the law even if by double effect I do shorten your life with the drug.

Somebody who’s in the ICU is voiceless when they are in critical care, on a ventilator, and unconscious. And so we have to protect them, because the mark of a society is how do we speak for people when they are vulnerable and don’t have a voice. And so in this case, I think we have to ask ourselves the difference between palliative care and euthanasia.

There was a beautiful paper published by Charlie Sprung in 2008 that involved 17 countries in Europe, over 30 ICUs, and they studied over 3,000 people. And the unique thing about this, Joel, was that doctors admitted in which patients they were intentionally trying to shorten the dying process. You couldn’t tell by dose, by the way, the doses were similar. But what the conclusions of the paper found were that there was a gray zone here which is very difficult to define, and we’ve got to talk about this more as a society and as medicine. As you went from palliative care to euthanasia on two different spectrums, what happened was palliative care is intent to relieve pain with doses that almost never could end a life, versus intent to shorten life with doses that almost always will shorten life.

The doses of 2,000 micrograms, 1,000 of fentanyl — that will almost always stop somebody from breathing. So those doses do fall into the category of almost always going to shorten somebody’s life.

Zivot: Look, I think that Thomas Aquinas, of course, spoke about the struggle of this in the doctrine of the double effect, and the distinction between what one intends and what one foresees. And I think to your point, what Dr. Husel intended, I suppose, cannot be known.

I can surmise his intent. I don’t think he had, you know, the history or the comportment of a murderer. Now, the issue of course for the court is the idea of how to gauge intent through action.

Normally as physicians, where we’re kind of engaged or interact with the law is through the concept of negligence, and negligence is something that we think of as a non-criminal wrong or a tort. What was unusual about Husel is that Husel was now charged with a criminal wrong, and a criminal wrong is constructed very differently than a non-criminal wrong.

In a criminal wrong, one needs two elements. It needs, first of all, the guilty act, which is referred to as actus reus. And then it also needs the guilty mind, which is mens rea. This is, I think, what you were alluding to, Wes, as to how to figure out what was his mind.

Now, where I think the court erred here is that they assumed that the act alone was where the guilty mind therefore must lie. It’s the same problem with this case in your state with the nurse, where an action alone was considered to be only the thing that a person with a guilty mind could possibly do. And that’s very troubling, that’s very troubling. I think the law here has really shown itself to be strikingly limited to navigate these very important end of life kinds of questions and practices that you and I are engaging in right now.

Ely: Excellent answer. And I’ll make a couple of comments. Actus reus and mens rea — I think in this case, there was actus reus. There was a dose given, as I said, which is almost certainly going to end up shortening someone’s life. A median time of death of 12 minutes is very unusual. Mens rea, I have no idea. I do not know what was in Husel’s mind, but I do know that the families were not informed that the patient was about to get a lethal dose of drug, and they did get what I absolutely consider a lethal dose of drug.

Again, I do not know his mind or his intent, but I will say this: in the circumstance of taking care of patients in the ICU, we have to always be aware that we do have the power to actus reus, to commit a harm against a person that can’t be reversed.

In this case, what was really striking, and this was a mind turner for me, was that the pain scores for many of these people were zero all throughout the day, meaning no indication of ongoing pain, until the moment that they received 1,000 or 2,000 mcgs of fentanyl and benzos. And then, all of a sudden they were at 10. That seems to me a very unusual thing, where somebody would out-of-the-blue go from zero to 10.

The most striking thing of all to me, and I didn’t even know this really until I reviewed these cases so in depth, was that — I’ve never seen this in 30 years of medicine — all 14 death notes were part of the DNR and the withdrawal of life support note.

Now, for the general public, usually as a doctor, I would write a note. I just conversed with the family and they believe the patient would want to not be resuscitated. Then hours later, we have now chosen to withdraw support, and then maybe hours or a day or two days later, the patient has now died. But in all 14 of these people, those three notes were in the same note. I’m making them DNR, I’m taking them off the vent, they’re dead.

That to me shows that these doses were part of an active shortening of the dying process. Whether he meant to do it or not, it happened. And that’s all I was speaking to. I never would want this guy to go to jail, but I do want us to protect society for vulnerable patients. We have to set the laws up and the rules within medicine so that we don’t take advantage of people who can’t speak for themselves.

Zivot: Well, I think that you and I agree on the importance of protecting vulnerable people. I think that’s the job of medicine. The people who are the majority need no protection. It’s always the minority and the vulnerable who require our protection.

Let me say a couple things. First of all, I think that actus reus — I would say that an act occurred, but whether that’s a guilty act, I think I would push back on. I just think that an act occurred. And I think that when we think about the conflict in bioethical practice, we can probably start with the very simple first two directives of secular ethics. The first being: do no harm. And the second one: do good. So non-maleficence and beneficence.

And I think, again, that was what Aquinas and others were kind of bumping up against — how can you do something that has two actions, where one action seems to be beneficial and one action seems to do harm? Around the bioethics table or at the bedside, we can discuss this. Where I think we got into trouble here is that the law decided it had something to say here in a way that I think was ultimately very problematic.

What I do know about these cases is that in every case a conversation took place. In every case, the family agreed that the patients would be made DNR, and most of the time, as we know in intensive care, patients die because we stop. That’s the normal way to die in intensive care. It’s an unusual action that people die in intensive care in the midst of chest compressions. That’s more uncommon than common.

So, now it might be claimed that the conversation was manipulated in some way, like in the Sprung paper that you referred to — are you talking about the Ethicus Trial? Is that what you’re talking about?

Ely: Yes.

Zivot: So in the Ethicus Trial, what was noteworthy is that if you look actually just from the physician’s perspective, they looked at three end endpoints — withdrawing, withholding, and active shortening — in that study. And what was noteworthy was that depending upon the geographic location within Europe and the religion of the particular physician, the practice varied.

Now, the thing about the ICU of course is that in a normal doctor-patient relationship, a patient can pick their doctor. In the ICU, the patient doesn’t pick their doctor. So, depending upon which week it happens to be, you’ll get one doctor or another. And what’s noteworthy too, is that doctors’ practices do vary. One doctor may practice one way and another doctor may practice another way. Patients, again, have no control over this. And it may in fact be that the week you happen to be in intensive care and, depending on which doctor you have, your outcomes could be quite different.

That’s a striking kind of problem. Now, none of that is murder. So, I want to keep coming back to that. You know, what Husel did I think is worthy of conversation, and it’ll be interesting to see if Husel returns to the practice of medicine and what he himself has learned from this. But I think that in terms of the variation of physician practice, our relationship with dosage, the way that we bring in our empathy, how we talk to patients and families — these are all very important subjects.

Ely: Sure. Let me close by saying that in no way do I know or surmise whether or not any conversations were manipulated by Dr. Husel. I have no idea. What I do think is that when people sign for their loved one to get DNR orders, they don’t sign on to get a dose of drug that will stop them from breathing. And that did happen, even though the families didn’t know it.

Now, importantly, you brought up the variation of physicians. We actually know from the New England Journal of Medicine, in Flanders, Belgium in the year 2013, a paper was published that showed that of times when people were given medicines to provide palliative care, 27% of the time (and this did not get brought up in the trial) doctors were deliberately giving a dose in Flanders, Belgium to end the patient’s life. The families were not told that they were getting that dose. The doctors did intend it, and that is considered a crime in Belgium. It’s considered murder in Belgium, but they weren’t criminally prosecuted.

And what I hope happens from the awareness that came about with Dr. Husel’s situation is that we all reconsider — and I know this actually is happening at the Society of Critical Care Medicine because people contacted me yesterday and said we’re going to review this for the upcoming guidelines of pain, anxiety, and delirium — that we’re going to address and what are reasonable doses. We can’t skip steps and jump to these high doses that cause chest restriction and lack of breathing without further first going through very low doses.

Also, let’s have a system of checks and balances so that we can calibrate one another and inform one another from within medicine, rather than having to go into the courtroom to do this, which I don’t even believe in. I’d rather this be done within the context of us within medicine.

Zivot: I think that the law struggles, and I think that the law here struggled greatly in trying to navigate an important subject that really should be under the purview of medicine. And it’s our job here, I think, to make sure that we are trying to engage this subject and do a better job of conveying to the public and to each other what we intend to be, so we can draw the distinction between the reduction of suffering, active euthanasia, and even in the most extreme, unusual example, the intentional killing of a person with malice.

Ely: I think we have to ask ourselves the question of where are we going and how are we gonna get there? And I think that the answer to the first question of where we’re going is that we should proceed in medicine to do a better job of relieving human suffering while staying within the boundaries of avoiding intentionally shortening someone’s life.

The way that I think we can do that is for doctors and nurses and bioethicists to have a system of checks and balances where when we deliver palliative care, we agree that the doses we’re giving are not likely to cause more harm than good, but rather to relieve pain, relieve anxiety, shortness of breath, et cetera. That we start at the lowest doses and then watch ourselves gradually increase so that we avoid this large jump towards doses, which are then on the spectrum of very likely to shorten somebody’s life, which then leaves us in an area that we don’t want to be in.

We don’t have the right to take someone’s life, but we absolutely have the intent and the vocational calling to relieve suffering.